-+ 0.00%
-+ 0.00%
-+ 0.00%

ConvaTec raises FY26 organic revenue growth forecast to 6.25%-7.0%, excluding InnovaMatrix

PUBT·11/18/2026 11:09:04
ConvaTec raises FY26 organic revenue growth forecast to 6.25%-7.0%, excluding InnovaMatrix
  • ConvaTec raised fiscal 2026 organic revenue growth guidance, excluding InnovaMatrix, to 6.25-7% from 5.5-6.5%.
  • Organic revenue growth excluding InnovaMatrix reached 6.6% in the 10 months ended October 31, led by Infusion Care and Continence Care.
  • Infusion Care growth guidance rose to double digits; Continence Care's outlook increased to mid- to high-single digits.
  • Adjusted operating margin guidance remained at least 23%, with adjusted diluted earnings per share still expected to grow by double digits.
  • Equity cash conversion guidance fell to about 90% from about 100%; expected cash adjusting items increased to about $30 million from $20 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ConvaTec Group plc published the original content used to generate this news brief on November 18, 2026, and is solely responsible for the information contained therein.